Plus Therapeutics, Inc. Announces Nasdaq Ticker Symbol Changes and Reverse Stock Split

NEXT STORY
Delcath Enhances Board of Directors With Appointment of Commercial Leader, John R. Sylvester
PREV STORY
Unum Therapeutics Announces New Appointments to its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®

RedHill has been granted the exclusive right to co-promote Mytesi® (crofelemer 125 mg delayed-release ...

author_avatar
NASDAQ Market News

Gritstone Oncology to Webcast a Review of the Clinical Immunogenicity Data from its Neoantigen-based Immunotherapies that will be Presented at the ESMO Immuno-Oncology Congress

author_avatar
NASDAQ Market News

View Smart Glass Selected for use in Walmart’s New Home Office Campus

author_avatar
NASDAQ Market News